Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Abstract A1-08: Comparative genomics study of FOXA/ER dual regulation in breast cancer and liver cancer
Li, Zhaoyu , Li, Zhaoyu

Cancer Research | November 20, 2015 | Volume: 75 | Issue: 22_Supplement_1 | Pages: A1-08-A1-08

10.1158/1538-7445.transcagen-a1-08 Get It

Abstract Estrogen, the female dominant hormone, has been found to play critical roles in cancers for over 100 years. In 1896, estrogen was found to promote the tumor growth of breast cancer; and in 1937, estrogen was found to prevent the tumor growth of liver cancer. After the estrogen receptor alpha (ERα) was identified in 1958, ERα-mediated estrogen signaling was found to promote or prevent the growth of breast cancer cells or liver cancer cells, respectively. Recent studies showed that ERα-mediated estrogen signaling in promoting the growth of breast cancer cells was dependent of forkhead box protein A1 (FOXA1). Our recent study showed that ERα-mediated estrogen signaling in preventing the growth of liver cancer cells also depended on FOXA factors (FOXA1 and FOXA2). Thus, FOXA-dependent ERα-mediated estrogen signaling plays opposite roles in the growth of breast cancer and liver cancer cells. Here, we applied genomic approaches to identify 184 FOXA/ER dual target genes that showed opposite expression in response to estrogen-mediated stimulation or suppression of cell growth in breast or liver cancer cells. Gene ontology analysis showed that the majority of these FOXA/ER dual target genes were involved in the processes of cell proliferation and growth, cell death, tissue development, and cancer. Manipulations of the expression of these target genes were able to reverse the growth of breast and liver cancer cells. Thus, these 184 FOXA/ER dual target genes provide us a novel set of potential biomarkers and therapeutic targets for both breast cancer and liver cancer. Note: This abstract was not presented at the conference. Citation Format: Zhaoyu Li. Comparative genomics study of FOXA/ER dual regulation in breast cancer and liver cancer. [abstract]. In: Proceedings of the AACR Special Conference on Translation of the Cancer Genome; Feb 7-9, 2015; San Francisco, CA. Philadelphia (PA): AACR; Cancer Res 2015;75(22 Suppl 1):Abstract nr A1-08.
Rapidly Appearing Sclerotic Vertebral Lesions in a Patient With an Infiltrative Mediastinal Mass
Mansfield, Aaron S. , White, Darin , Mansfield, Aaron S

JAMA Oncology | November 19, 2015 | Volume: 2 | Issue: 2 | Pages: 267

10.1001/jamaoncol.2015.4576 | PMID 26584205 Get It

Urologic-Induced Complications of Prophylactic Ureteral Localization Stent Placement for Colorectal Surgery Cases
Pathak, Ram A. , Taylor, Abby S. , Alford, Scott, Broderick, Gregory A. , Igel, Todd C., Petrou, Steven P. , Wehle, Michael J., Thiel, David D. , Young, Paul R.

Journal of Laparoendoscopic & Advanced Surgical Techniques | November 19, 2015 | Volume: 25 | Issue: 12 | Pages: 966-970

10.1089/lap.2015.0345 | PMID 26583763 Get It

Abstract Purpose: A prophylactic ureteral localization stent (PULSe) placed by urologists aids in intraoperative localization and detection of suspected ureteral injury during complex colorectal surgery (CRS) cases. We evaluated the incidence and management of urologic-induced complications secondary to PULSe placement during CRS cases at a single center. Materials and Methods: We performed a retrospective review of all patients who underwent cystoscopy and PULSe placement at the time of CRS over a 12-month period. Bilateral 5 French ×70-cm TigerTail ® (Bard Medical Division, Covington, GA) PULSe devices were placed without assistance of routine fluoroscopy. Results: Ninety-nine patients (mean age, 58.1 years; range, 17–88 years) underwent bilateral PULSe placement, with a male:female ratio of 44:55 and a mean body mass index of 26.8 (17.0–38.6) kg/m 2 . Mean pre- and postprocedural creatinine levels were 0.91 and 1.01 mg/dL, respectively. Twenty-two of 99 (22%) cases utilized a guidewire to aid in placement of PULSe. Four Clavien grade IIIb complications occurred: mucosal edema, reflex anuria, ureteral perforation, and ureteral obstruction secondary to significant clot burden. Three of the grade IIIb complications were managed endoscopically with double-J stent placement. The ureteral perforation case required percutaneous nephrostomy tube placement. Subgroup analysis of the four grade IIIb complications revealed a mean age of 62.3 years, body mass index of 26.98 kg/m 2 , and pre- and postprocedural creatinine levels of 0.95 and 4.83 mg/dL, respectively. Only one of the four grade IIIb complications utilized a guidewire prior to PULSe placement. Conclusions: The incidence of Clavien grade III urologic-induced complications during PULSe placement is approximately 2% (4/188). Mandatory adoption of fluoroscopy and guidewires may be required to minimize complications of PULSe placement.
The Copenhagen Muscle Research Centre (CMRC) 1994–2004
Joyner, M. J., Kjær, Michael , Larsen, P O, Joyner, Michael J. , Joyner, Michael J

Scandinavian Journal of Medicine & Science in Sports | November 19, 2015 | Volume: 25 | Issue: S4 | Pages: 22-28

10.1111/sms.12598 | PMID 26589113 Get It

This paper presents an impressionistic summary of the formation, activities, accomplishments, and impact of the Copenhagen Muscle Research Centre (CMRC) from 1994 to 2004. The history of the CMRC is viewed in the context of the goals of the original program, the tradition of excellence in exercise physiology in Copenhagen since the time of August Krogh, and the structure of the center. The key role of Professor Bengt Saltin as a visionary, flexible, and inclusive leader is highlighted.
False Lumen Embolization to Treat Disseminated Intravascular Coagulation After Thoracic Endovascular Aortic Repair of Type B Aortic Dissection
Mendes, Bernardo C. , Reed, Nanette R., Pruthi, Rajiv K. , Oderich, Gustavo S. , Erben, Young

Journal of Endovascular Therapy | November 19, 2015 | Volume: 22 | Issue: 6 | Pages: 938-941

10.1177/1526602815607185 | PMID 26384395 Get It

Purpose: To present a rare case of disseminated intravascular coagulation (DIC) after thoracic endovascular aortic repair (TEVAR) and its novel treatment. Case Report: A 55-year-old man presented with DIC 10 months after TEVAR for chronic type B aortic dissection and descending thoracic aortic aneurysm. He had persistent retrograde flow in the false lumen with a stable aneurysm diameter. The false lumen was embolized with multiple Amplatzer plugs, which promoted false lumen thrombosis. Laboratory evaluation on postoperative day 7 demonstrated resolution of the coagulopathy. Follow-up at 18 months revealed no recurrent DIC; computed tomography angiography showed a stable aortic diameter and excluded thoracic aneurysm sac. Conclusion: This case demonstrates an unusual, potentially fatal postoperative complication of endovascular treatment of type B aortic dissections successfully treated with an innovative endovascular solution.
TRANSLATIONAL BIOINFORMATICS 101
Tenenbaum, Jessica D. , Madhavan, Subha , Frey, Lewis J. , Freimuth, Robert R. , Denny, Joshua C.

Biocomputing 2016 | November 19, 2015 | Volume: No volume available | Issue: No issue available | Pages: 552-556

10.1142/9789814749411_0050 Get It

Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy
Abaza, Ronney , Shabsigh, Ahmad , Castle, Erik P., Rogers, Craig , Menon, Mani, Aron, Monish, Sundaram, Chandru P. , Castle, Erik, Allaf, Mohamad E , Hu, Jim C. , Eun, Daniel

Journal of Urology | November 19, 2015 | Volume: 195 | Issue: 4 Part 1 | Pages: 865-871

10.1016/j.juro.2015.09.094 | PMID 26602891 Get It

Influence of amyloid and APOE on cognitive performance in a late middle‐aged cohort
Mielke, Michelle M. , Hagen, Clinton E., Christianson, Teresa J., Roberts, Rosebud O., Vemuri, Prashanthi , Lowe, Val J. , Kremers, Walter K. , Jack, Clifford R. , Petersen, Ronald C. , Machulda, Mary M. , Knopman, David S. , Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Kremers, Walter K

Alzheimer's & Dementia | November 19, 2015 | Volume: 12 | Issue: 3 | Pages: 281-291

10.1016/j.jalz.2015.09.010 | PMID 26602629 Get It

AbstractIntroductionFew studies have examined the effects of amyloid and apolipoprotein E (APOE) genotype on cognition among middle‐aged individuals.MethodsWe included 464 cognitively normal, test‐naïve, participants with Pittsburgh compound B positron emission tomography amyloid imaging, mean age of 62.7 (range, 51–71 years), enrolled in the Mayo Clinic Study of Aging. Participants completed multiple cognitive assessments, including a standard neuropsychological battery and the CogState computerized battery, over 30 months of follow‐up. Linear mixed models were used to examine the effects of amyloid and APOE genotype on baseline cognition and cognitive decline.ResultsElevated amyloid was not associated with tests of episodic memory but did predict declines on tests of executive function. APOE genotype was not associated with cognition. Among APOE ɛ4 noncarriers, higher amyloid was predictive of decline on tests of executive function and on one episodic memory test.DiscussionElevated amyloidosis and APOE genotype do not appear to exert a dramatic influence on cognition in middle age.
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Patnaik, Amita , Haluska, Paul , Erlichman, Charles , Papadopoulos, Kyriakos P. , Lensing, Janet L., Beeram, Muralidhar , Molina, Julian R. , Rasco, Drew , Arcos, Rebecca R., Kelly, Claudia S., Wijayawardana, Sameera R. , Zhang, Xuekui , Bell, Robert L., Shi, Peipei , Kulanthaivel, Palaniappan, Pitou, Celine, Mulle, Lynette B., Farrington, Daphne L., Chan, Edward M. , Tolcher, Anthony W. , Stancato, Louis F. , Bell, Robert, Goetz, Matthew P.

Clinical Cancer Research | November 18, 2015 | Volume: 22 | Issue: 5 | Pages: 1095-1102

10.1158/1078-0432.ccr-15-1718 | PMID 26581242 Get It

Abstract Purpose: p38 MAPK regulates the production of cytokines in the tumor microenvironment and enables cancer cells to survive despite oncogenic stress, radiotherapy, chemotherapy, and targeted therapies. Ralimetinib (LY2228820 dimesylate) is a selective small-molecule inhibitor of p38 MAPK. This phase I study aimed to evaluate the safety and tolerability of ralimetinib, as a single agent and in combination with tamoxifen, when administered orally to patients with advanced cancer. Experimental Design: The study design consisted of a dose-escalation phase performed in a 3+3 design (Part A; n = 54), two dose-confirmation phases [Part B at 420 mg (n = 18) and Part C at 300 mg (n = 8)], and a tumor-specific expansion phase in combination with tamoxifen for women with hormone receptor–positive metastatic breast cancer refractory to aromatase inhibitors (Part D; n = 9). Ralimetinib was administered orally every 12 hours on days 1 to 14 of a 28-day cycle. Results: Eighty-nine patients received ralimetinib at 11 dose levels (10, 20, 40, 65, 90, 120, 160, 200, 300, 420, and 560 mg). Plasma exposure of ralimetinib (Cmax and AUC) increased in a dose-dependent manner. After a single dose, ralimetinib inhibited p38 MAPK–induced phosphorylation of MAPKAP-K2 in peripheral blood mononuclear cells. The most common adverse events, possibly drug-related, included rash, fatigue, nausea, constipation, pruritus, and vomiting. The recommended phase II dose was 300 mg every 12 hours as monotherapy or in combination with tamoxifen. Although no patients achieved a complete response or partial response,19 patients (21.3%) achieved stable disease with a median duration of 3.7 months, with 9 of these patients on study for ≥6 cycles. Conclusions: Ralimetinib demonstrated acceptable safety, tolerability, and pharmacokinetics for patients with advanced cancer. Clin Cancer Res; 22(5); 1095–102. ©2015 AACR.
Psychosocial Dimensions and Functioning in Youth With Postural Orthostatic Tachycardia Syndrome
McTate, Emily , Weiss, Karen E. , McTate, Emily

Clinical Pediatrics | November 18, 2015 | Volume: 55 | Issue: 10 | Pages: 979-982

10.1177/0009922815616890 | PMID 26581359 Get It